Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trial. - Wang XY; Zhang XM; Wang L; Gao LR; Chen K; Feng XL; Rao W; Zheng R; Wu YP; Song YW; Fang H; Chen B; et al. (The Lancet. Haematology, 2025)